FOLH1 and pachyonychia congenita: In the current study, we provide oncological and patient-reported outcomes with a special focus on HRQOL of a contemporary cohort of patients that underwent metastasis-directed salvage therapies for PSMA-PET/CT-based nodal recurrent PC.